Adapting children's speech hearing tests into other languages
Develops a method to adapt children's speech hearing tests for other languages.
Key facts
- Who runs it
- Semmelweis University
- Where
- Hungary1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Adaptation of Pediatric Speech Audiometry Tests Into Other Languages
- Status
- Recruiting
- People taking part
- 120 people, planned
- Started
- 5 Aug 2024
- Planned end
- Jul 2026
- Type of study
- Observational, 6 groups
- Record updated
- 26 January 2026
Who can take part
The trial is looking for children aged 2 to 7 years with normal hearing or with lasting hearing loss. It helps adapt a children's speech hearing test into another language.
- Age
- 2 Years to 7 Years, in age groups 2-4,5; 4,5-5,5; 5,5-7
- Sex
- All
- Disease stage
- Control groups: normal hearing, checked by hearing tests (pure tone audiometry and tympanometry). Hearing-loss groups: stable sensorineural hearing loss (inner ear or nerve type), confirmed by hearing tests.
- Main reasons for not taking part
- Signs of a cold or other upper airway infection
- Known speech or language development disorders
- Cognitive disorders (problems with thinking and learning)
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- Age: limits for age groups: 2-4,5; 4,5-5,5; 5,5-7, respectively
- For control goups: normal hearing verified by pure tone audiometry and tympanometry
- For hearing-impairment groups: stable sensorineural hearing loss confirmed by audiological diagnostics
Who cannot take part
- Children presenting with symptoms of upper respiratory tract infections
- Known speech-language developmental disorders
- Cognitive disorders
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Hearing loss or screening
This trial is currently available in Hungary.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The objective of this study was to offer a comprehensive framework for the adaptation of speech audiometric tests into other languages. To date, this is the first universal protocol of its kind that systematically considers linguistic, phonological, and audiological aspects.
Read full original descriptionShow less
The present paper provides a protocol and an example for adaptation and standardization of the Mainzer Audiometric Test for Children (MATCH) to another language.
The 6 groups in the trial
- Group 1 N
Children 2 - 4,5 years of age; with normal hearing
- Group 2 N
Children 4,5 - 5,5 years of age; with normal hearing
- Group 3 N
Children 5,5 - 7 years of age; with normal hearing
- Group 1 P
Children 2 - 4,5 years of age; with impaired hearing
- Group 2 P
Children 4,5 - 5,5 years of age; with impaired hearing
- Group 3 P
Children 5,5 - 7 years of age; with impaired hearing
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Methodological Guide for the Adaptation of Pediatric Speech Audiometry Tests Into Other Languages
- Plain-language title
- Adapting children's speech hearing tests into other languagesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07156825, who can take part
- Publications
- Record updated
- 26 January 2026